Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Riedl

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Current Hypertension Reports|March 20, 2017
The Gut Microbiome, Energy Homeostasis, and Implications for HypertensionRuth A Riedl, Samantha N Atkinson, Colin M L Burnett, et al.
The Biochemical Journal|February 24, 2005
Down-regulation of Rap1 activity is involved in ephrinB1-induced cell contractionJurgen A Riedl, Dominique T Brandt, Eduard Batlle, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 7, 2020
Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature ReviewJoel P Brooks, Cristine Radojicic, Marc A Riedl, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 25, 2023
Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstatMarc A Riedl, Daniel Soteres, J Wesley Sublett, et al.
Allergy and Asthma Proceedings|May 13, 2021
Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burdenTimothy J Craig, Aleena Banerji, Marc A Riedl, et al.
Allergy|April 19, 2025
Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary AngioedemaMarc A Riedl, Aaron Yarlas, Laura Bordone, et al.
Allergy and Asthma Proceedings|May 13, 2021
Patient perspectives on the treatment burden of injectable medication for hereditary angioedemaCristine Radojicic, Marc A Riedl, Timothy J Craig, et al.
International Archives of Allergy and Immunology|June 9, 2026
Lanadelumab in Hereditary Angioedema: Extending Dose Intervals from Every 2 Weeks to Every 4 WeeksMarc A Riedl, Daniel Soteres, Mark A Davis-Lorton, et al.
Allergy and Asthma Proceedings|March 25, 2015
Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedemaMarc A Riedl, William R Lumry, Paula Busse, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 3, 2026
Inpatient cardiac computed tomography angiography in Germany between 2005 and 2023: a nationwide registry studyKatharina A Riedl, Bianca Strauß, Alexander Lenz, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Current Hypertension Reports|March 20, 2017
The Gut Microbiome, Energy Homeostasis, and Implications for HypertensionRuth A Riedl, Samantha N Atkinson, Colin M L Burnett, et al.
The Biochemical Journal|February 24, 2005
Down-regulation of Rap1 activity is involved in ephrinB1-induced cell contractionJurgen A Riedl, Dominique T Brandt, Eduard Batlle, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 7, 2020
Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature ReviewJoel P Brooks, Cristine Radojicic, Marc A Riedl, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 25, 2023
Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstatMarc A Riedl, Daniel Soteres, J Wesley Sublett, et al.
Allergy and Asthma Proceedings|May 13, 2021
Caregivers' role in managing hereditary angioedema and perceptions of treatment-related burdenTimothy J Craig, Aleena Banerji, Marc A Riedl, et al.
Allergy|April 19, 2025
Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary AngioedemaMarc A Riedl, Aaron Yarlas, Laura Bordone, et al.
Allergy and Asthma Proceedings|May 13, 2021
Patient perspectives on the treatment burden of injectable medication for hereditary angioedemaCristine Radojicic, Marc A Riedl, Timothy J Craig, et al.
International Archives of Allergy and Immunology|June 9, 2026
Lanadelumab in Hereditary Angioedema: Extending Dose Intervals from Every 2 Weeks to Every 4 WeeksMarc A Riedl, Daniel Soteres, Mark A Davis-Lorton, et al.
Allergy and Asthma Proceedings|March 25, 2015
Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedemaMarc A Riedl, William R Lumry, Paula Busse, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 3, 2026
Inpatient cardiac computed tomography angiography in Germany between 2005 and 2023: a nationwide registry studyKatharina A Riedl, Bianca Strauß, Alexander Lenz, et al.
Pageof 20